Newswise — Journalists are invited to report on the latest developments in the treatment of allergic diseases including asthma and immunologic disorders presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Meeting at the Anaheim Convention Center, Nov. 4-9, 2005. The theme is "Vade Mecum" " a concise source of practical information and guidance you can take with you.
A pre-meeting "Rhinosinusitis Collegium" on Nov. 4 will be jointly sponsored by the ACAAI and the European Academy of Allergology and Clinical Immunology. Internationally known experts will discuss the relationship of rhinosinusitis to IgE mediated allergy; nasal polyposis and the asthma-aspirin connection; allergic fungal sinusitis; the changing role of endoscopic sinus surgery; and antibiotic and anti-inflammatory therapies.
Physicians, researchers and international experts will present and discuss scientific data on conditions that afflict more than 50 million Americans, including the following topics:
~ Asthma in women: effects on life cycle changes and management during pregnancy (Nov. 4)
~ Asthma in subpopulations: genetic variations, particulates and viral infections (Nov. 4)
~ Allergen immunotherapy: sublingual vs. subcutaneous (Nov. 5)
~ The innate immune system: how it works and how it's related to allergy (Nov. 5)
~ Preventing the atopic march: avoidance of allergens vs. intentional exposure (Nov. 5)
~ Severe asthma: history, treatment options and economic analysis of treatment cost (Nov. 6)
~ One linked airway: treatment of the upper airway and its impact on the lower airway (Nov. 6)
~ Skin and mucosal diseases: management of cutaneous allergy diseases (Nov. 7)
~ Primary immunodeficiency: diagnosis, common variable, clinical clue (Nov. 7)
~ Asthma and COPD treatment: consensus and controversy (Nov. 8)
~ Socioeconomics: US Healthcare, electronic prescription writing, and electronic medical records, and the significance of Black Box Warnings (Nov. 8)
During a special half day intensive program on Nov. 9, "When Fungi Aren't Fun," experts will discuss mold-related allergic diseases, mycotoxins, toxic molds and conducting air quality studies.
The Annual Meeting program consists of more than 115 scientific sessions, 35 workshops, 350 technical exhibits and 250 abstract presentations. The expected 4,000 meeting participants include some 1,700 physicians, 200 allied health professionals, 100 office managers and 1,200 pharmaceutical representatives.
The preliminary program and downloadable housing and registration forms are online at www.acaai.org/Member. All media attending the meeting must present credentials to register for an ACAAI Press Badge for free access to educational programs.
The ACAAI is a professional medical organization, headquartered in Arlington Heights, Ill., comprising nearly 5,000 qualified allergists-immunologists and related health care professionals. The College is dedicated to the clinical practice of allergy, asthma and immunology through education and research to promote the highest quality of patient care.